newsfilter
← Latest News
ACCESS Newswire·

Statera Biopharma Receives Nasdaq Listing Determination; Hearing Requested to Address Filing Delinquency

FORT COLLINS, CO / ACCESSWIRE / September 9, 2022 / Statera Biopharma, Inc. (NASDAQ:STAB) (the "Company" or "Statera Biopharma"), a biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, toda